Camden Prop Trust Financials - Benzinga

Camden Property Trust

CPTNYSE

Trade with Public

Trade with Public

$97.40

-1.00-1.02%

al cierre: Sep 28, 5:00 PM EST

$97.63

-0.77-0.78%

Premercado: 8:39 AM EST

Dividendo: La fecha límite del dividendo es hoy

Panorámica general Noticias Previsión de beneficios Eventos Precios objetivoFinanzasSentimiento Propiedad Dividendos Comparar Opciones Informe de acciones

Camden Prop Trust Financials

Camden Prop Trust (CPT) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Camden Prop Trust Narrows FY2026 FFO Guidance from $6.60-$6.90 to $6.68-$6.82 vs $6.74 Est

Camden Prop Trust (NYSE:CPT) narrows FY2026 FFO guidance from $6.60-$6.90 to $6.68-$6.82 vs $6.74 analyst estimate..

Benzinga Newsdesk

PRO
Camden Prop Trust Sees Q3 FFO $1.67-$1.71 vs $1.64 Est

Camden Prop Trust (NYSE:CPT) is looking for Q3 FFO of $1.67-$1.71 vs $1.64 analyst estimate..

Benzinga Newsdesk

PRO
Camden Prop Trust Q2 FFO $1.68 Beats $1.67 Estimate, Sales $392.944M Beat $392.912M Estimate

Camden Prop Trust (NYSE:CPT) reported quarterly earnings of $1.68 per share which beat the analyst consensus estimate of $1.67 by 0.6 percent. This is a 1.18 percent decrease over earnings of $1.70 per share from the

Benzinga Newsdesk

PRO
Camden Prop Trust Affirms FY2026 FFO Guidance of $6.60-$6.90 vs $6.73 Est

Camden Prop Trust (NYSE:CPT) affirms FY2026 FFO guidance from $6.60-$6.90 to $6.60-$6.90 vs $6.73 analyst estimate..

Benzinga Newsdesk

PRO
Camden Prop Trust Sees Q2 FFO $1.65-$1.69 vs $1.67 Est

Camden Prop Trust (NYSE:CPT) is looking for Q2 FFO of $1.65-$1.69 vs $1.67 analyst estimate..

Benzinga Newsdesk

PRO
Camden Prop Trust Q1 FFO $1.70 Beats $1.64 Estimate, Sales $388.773M Beat $388.051M Estimate

Camden Prop Trust (NYSE:CPT) reported quarterly earnings of $1.70 per share which beat the analyst consensus estimate of $1.64 by 3.66 percent. This is a 1.16 percent decrease over earnings of $1.72 per share from the

Benzinga Newsdesk

© 2026 Benzinga | All Rights Reserved